Completed
Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis
NCT05185947
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +43 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States